PS-ON News and Media
PS-ON Social Media
Follow @NCIPhySci on Twitter for the latest research and updates from PS-ON and the NCI Cancer Tissue Engineering Collaborative.
Recent PS-ON News
Genetic Engineering and Biotechnology News: Fatty Acid Uptake Profiling Advances Single-Cancer-Cell Understanding
Features a Journal of the American Chemical Society study by PS-ON researchers at the Institute for Systems Biology. They developed a technique to profile fatty acid uptake in single cells, which was integrated with a protein analysis platform to determine relationships between fatty acid influx, oncogenic signaling, and glioblastoma proliferation.
WFMZ-TV 69: Looking at Tumors Through a New Lens: New Research May Improve Efficacy of Glioblastoma Immunotherapy
Highlights a Nature Communications study by PS-ON researchers at the Institute for Systems Biology. They developed a new approach to study tumors, which revealed features that determine the effectiveness of immunotherapy.
Medium: Engineering Immune Cells to Invade Tumors
Features a recent Nature study by PS-ON investigators at the University of Minnesota showing the potential of engineered T cells to better infiltrate tumor tissue
Phys.org: Researchers Reveal 3D Structure Responsible for Gene Expression
Summarizes a Science study by PS-ON investigators at Northwestern University with the first 3D image of the Mediator-bound pre-initiation complex.
Chemical & Engineering News: Cancer Cells Can Evolve by Combining
Highlights a Nature Ecology and Evolution study by PS-ON investigators at Moffitt Cancer Center, which revealed that when cancer cells fuse, they combine genetic materials, increasing diversity.
Nature Bioengineering – Behind the Paper: Towards Providing Physicians with a Quantitative Tool for Optimizing Immunotherapy Treatment Protocols for Each Individual Patient
Shares the background and story of a Nature Biomedical Engineering study by researchers at Houston Methodist PS-ON. They built a mathematical model to predict responses to immunotherapy.
PS-ON Videos: Patient Advocacy
Basser Center's Black & BRCA initiative: Empowering GENErations: Have You Had the Family Cancer Talk?
This virtual panel, including Ashley Dedmon (a PS-ON patient advocate), Dr. Payal Shah (an oncologist), and Tiffiney Carter (a genetic counselor) focuses on discussing hereditary cancer with your family.
PS-ON Advocate Spotlights and Partnering with Advocates Break-Out Sessions
This YouTube playlist of videos from the 2020 PS-ON Annual meeting features PS-ON patient advocates (including Susan Samson, Bob Riter, Valencia Robinson, Mariah McMahon, and Anne Meyn) discussing PS-ON patient advocacy activities.
Tedx Talk: The Generational Impact of Cancer - BRCA2 Positive
Ashley Dedmon, a PS-ON patient advocate, discusses the generational impact that cancer has had on her life, including a family history of cancer, her BRCA2 journey, and her experience with genetic testing.
Advocate Chat at the 2019 Alamo Breast Cancer Foundation Symposium
Dr. Carole Baas, the PS-ON National Advocate, interviews Dr. Jeremy Mason about how he became involved in cancer research, his current work in predictive modeling, and what the future holds for his studies.
Celebrating a Decade of PS-ON Research
This YouTube playlist of videos from the 2020 PS-ON Annual meeting features investigators (including Dr. Bob Gatenby, Dr. Claudia Fischbach, Dr. Denis Wirtz, Dr. Thomas Halloran, and Dr. Carole Baas) describing a decade of physical sciences-oncology research at their PS-ON Centers.
Bill Nye Saves the World — With Help From Dr. Kristin Swanson
Dr. Kristin Swanson, a PS-ON investigator at the Mayo Clinic in Arizona, discusses how her lab uses mathematical oncology to match patients to optimal treatments on Bill Nye’s Netflix show.
TedxMinneapolis: How cell phones and video gaming can help cancer patients
Dr. David Odde, a PS-ON investigator at the University of Minnesota, shares how cell phones and video gaming can help cancer patients by building computer models that predict patient prognosis and point to potential therapeutic strategies.